Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
Utilization of VigiFlow, VigiBase, VigiLyze, and VigiAccess in pharmacovigilance researchPharmacovigilance plays a critical role in monitoring, assessing, and preventing adverse effects associated with pharmaceutical products.The Uppsala Monitoring Centre (UMC, Uppsala, Sweden) has developed several tools-VigiFlow, VigiBase, VigiLyze, and VigiAccess-to enhance global pharmacovigilance efforts and ensure robust data management and validation.This section details the utilization of these tools in our research.
Authors
- Ho Geol Woo (ORCID: https://orcid.org/0000-0001-6489-0100)
- Jaeyu Park (ORCID: https://orcid.org/0009-0005-2009-386X)
- Dong Keon Yon (ORCID: https://orcid.org/0000-0003-1628-9948)
- Jaehyeong Cho (ORCID: https://orcid.org/0000-0001-7213-5033)
- Yesol Yim (ORCID: https://orcid.org/0009-0006-3618-2354)
- Jiyeon Oh (ORCID: https://orcid.org/0009-0005-3291-4370)
- Hyesu Jo
Institutions
- Kyung Hee University (KR)
- Kyung Hee University Medical Center (KR)
- CHA University (KR)
Publication Details
- Journal
- Journal of Stroke
- Published
- 2024-09-13
- DOI
- https://doi.org/10.5853/jos.2024.01536
- Citations
- 9
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- World Health Organization
- National Research Foundation
- National Research Foundation of Korea
- Iran Telecommunication Research Center
- Ministry of Science and ICT, South Korea
- Institute for Information and Communications Technology Promotion